BioVersys AG Alternatives & Competitors
12 companies similar to BioVersys AG — Leadership in overcoming the antibiotic resistance crisis.
Companies similar to BioVersys AG
Adaptive Phage Therapeutics
To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cu...
Apidel
Revolutionizing Therapeutics through Cutting-Edge Drug Delivery Solutions
EOLO PHARMA
Cutting-Edge Pharmacological Treatment for Obesity
Petra Pharma
Pioneering novel therapies to address cancer and metabolic disorders by targeting essentia...
Rival Readout
Competing with BioVersys AG? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Maxwell Biosciences
Next Generation Anti-Infectives: A drug platform confirmed by independent labs to destroy...
Promontory Therapeutics
Phase 2 stage biotech company developing novel small-molecule anti-cancer immunotherapies.
Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic,...
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Recce Pharmaceuticals Ltd
Recce Pharmaceuticals (ASX:RCE) is pioneering a New Class of Synthetic Anti-Infectives to...
Allecra Therapeutics
Our Mission: Answering the call to action to fight antibiotic resistance
About BioVersys AG
BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company founded in 2008. It focuses on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. The company's award-winning TRIC technology h...
Pharmaceuticals, Antimicrobial Resistance, Drug Development, Microbiome Modulation, Small Molecules, Clinical Stage, Swiss Company, Research And Development, Nosocomial Infections, Acinetobacter Baumannii, Tuberculosis, Collaboration With GlaxoSmithKline, University Consortium, TechPark Basel
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BioVersys AG: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BioVersys AG on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.